Adynxx Reports Second Quarter 2019 Financial Results
14 août 2019 07h00 HE
|
Adynxx, Inc.
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical
10 mai 2019 06h00 HE
|
Adynxx, Inc.
Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously...